R 281104Z JUN 05 – June 28, 2005FM AMEMBASSY BRASILIATO SECSTATE WASHDC 1902SUBJECT: BRAZIL GIVES ABBOTT TEN DAYS BEFORE BREAKING PATENT 1. (U) SENSITIVE BUT UNCLASSIFIED 2. (U) Summary. On Friday June 24, the GoB announced a declaration of “public… Continue Reading →
R 031944Z JUN 05 – June 3, 2005FROM: American Embassy BrasiliaTO: Secretary of State, Washington, D.C.SUBJECT: AMBASSADOR MEETS WITH U.S. PHARMACEUTICAL FIRMS THREATENED WITH LICENSING 1. (SBU) Summary. On May 24 and 25, U.S. pharmaceutical companies Gilead Sciences, Abbott Laboratories,… Continue Reading →
The attached is a February 24, 2005 letter signed by 162 experts, asking the World Health Organization to Evaluate New Treaty Framework for Medical Research and Development The proposal for a Medical R&D Treaty (MRDT) was designed as an alternative… Continue Reading →
February 16, 2005 109th Congress, 1st Session Issue: Vol. 151, No. 17 — Daily Edition [Pages S1498-S1499] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] THE DOHA DECLARATION AND THE TRADE PROMOTION AUTHORITY ACT OF 2002 Mr.… Continue Reading →
Sep 16, 2010 A New Trade Framework for Global Healthcare R&D[1] Access to Medicines and the Financing of Innovations in Health Care Workshop Hosted by the Program on Science, Technology, and Global Development, The Earth Institute at Columbia University, and… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading →
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents WHO meeting in Harare, ZimbabweAugust 21, 2001(with additional references to November Doha declaration) James LoveConsumer Project on Technology I. Introduction. TRIPS obligations raise broad public health… Continue Reading →
Ralph Nader P.O. Box 19312 Washington, DC 20036 July 23, 2001 Dr. Gro Harlem Brundtland Director-General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Dr. Brundtland: It has been encouraging in recent years to see the WHO… Continue Reading →
Compulsory Licensing: Models For State Practice In Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord Prepared for the United Nations Development Programme January 21, 2001 James Love Consumer Project on Technology http://www.cptech.org Introduction.1 This note addresses… Continue Reading →
2000: Paying for health care R&D – Carrots and Sticks James Love* October 19, 2000 *Thirukumaran Balasubramaniam provided research for this paper. Table of Contents Introduction Failures of the Market Investors cannot appropriate all the benefits of research. R&D is… Continue Reading →